Global Skin Biopsy

Skin Biopsy Comprehensive Study by Disease Type (Skin Cancer, Actinic Keratosis, Dermatitis, Psoriasis, Fungal Infections, Eczema, Others), Techniques (Shave Biopsy, Punch Biopsy, Wedge Biopsy, Saucerization Biopsy, Excisional Biopsy, Incisional Biopsy), Devices (Biopsy Guns, Biopsy Curettes And Punches, Guidance Systems, Biopsy Forceps, Biopsy Needles, Others), End User (Hospital and Clinics, Diagnostic Laboratories, Multispecialty Clinics, Other) Players and Region - Global Market Outlook to 2028

Skin Biopsy Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Skin Biopsy Market Overview:
A skin biopsy is a procedure that removes a small sample of skin for testing. The procedure can help diagnose a skin lesion (an abnormal skin area). The skin sample is looked at under a microscope to check for skin cancer, various skin conditions, or skin infections. An increase in the prevalence of skin conditions increases the demand for skin biopsy thereby leading to a rise in the demand for skin biopsy treatment.

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Significant Investments by the Government to Improve Healthcare Infrastructure

Market Growth Drivers:
The surge in Demand for Advanced Healthcare Facilities, Rise in Prevalence of Skin Cancer Cases and Development of the Medical Tourism Industry in Emerging Countries

Challenges:
Side Effects Of Skin Biopsy Treatment May Negatively Influence The Market.

Restraints:
Lack of Awareness about Advanced Diagnostic Techniques and New Imaging Technology May Reduce Need for Skin Biopsies

Opportunities:
Rise in Technology Advancement of Virtual Histology and New Product Innovations, Product Launches, and Approvals

Competitive Landscape:
Skin Biopsy Market is a fragmented market due to the presence of a large number of established competitors. The key players are highly focused on developing and innovating new virtual histology technology to maintain their market position. The increasing demand for skin biopsy and also rise in the demand for skin biopsy treatment is the main driver of market growth. The companies are also planning strategic activities like partnerships, collaboration, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.
Some of the key players profiled in the report are AccuTec, Inc. (Mexico), Cardinal Health Inc. (United States), Innovia Medical (United States), Integra LifeSciences (United States), Vernacare (United Kingdom), Becton (United States), Dickinson and Company (United Kingdom), KAI Group (Japan), Paramount Surgimed Limited (India), World Precision Instruments (United States) and Merit Medical Systems (United States). Considering Market by Disease Type, the sub-segment i.e. Skin Cancer will boost the Skin Biopsy market. Considering Market by Techniques, the sub-segment i.e. Shave Biopsy will boost the Skin Biopsy market. Considering Market by Devices, the sub-segment i.e. Biopsy Guns will boost the Skin Biopsy market. Considering Market by End User, the sub-segment i.e. Hospital and Clinics will boost the Skin Biopsy market.

Latest Market Insights:
In October 2019, Innovia Medical announced a partnership with DTR Medical. The acquisition of DTR Medical strengthens Innovia's global presence in the otolaryngology and ophthalmology markets, and opened new opportunities in areas such as obstetrics and gynecology, and general surgery. Surgical products include rotary biopsy punches, Frazier suction handles, Tibbs arterial cannulas, and ear speculums.

In September 2022, Merit Medical Systems launched the Temno Elite soft tissue biopsy system in South Jordan, Utah, and the USA. Merit designed the Temno Elite for use in a variety of soft tissue locations. These include suspected lesions of the liver, lungs, lymph nodes, kidneys, and other soft tissues. This launch helped merit medical systems to expand their presence in the skin biopsy market.

What Can be Explored with the Skin Biopsy Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Skin Biopsy Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Skin Biopsy
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Skin Biopsy market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Skin Biopsy market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Research and Development (R&D) companies, Market research and consulting service providers, Government Agencies and End User Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Disease Type
  • Skin Cancer
  • Actinic Keratosis
  • Dermatitis
  • Psoriasis
  • Fungal Infections
  • Eczema
  • Others

By Techniques
  • Shave Biopsy
  • Punch Biopsy
  • Wedge Biopsy
  • Saucerization Biopsy
  • Excisional Biopsy
  • Incisional Biopsy

By Devices
  • Biopsy Guns
  • Biopsy Curettes And Punches
  • Guidance Systems
  • Biopsy Forceps
  • Biopsy Needles
  • Others

By End User
  • Hospital and Clinics
  • Diagnostic Laboratories
  • Multispecialty Clinics
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The surge in Demand for Advanced Healthcare Facilities
      • 3.2.2. Rise in Prevalence of Skin Cancer Cases
      • 3.2.3. Development of the Medical Tourism Industry in Emerging Countries
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Of Skin Biopsy Treatment May Negatively Influence The Market.
    • 3.4. Market Trends
      • 3.4.1. Significant Investments by the Government to Improve Healthcare Infrastructure
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Skin Biopsy, by Disease Type, Techniques, Devices, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Skin Biopsy (Value)
      • 5.2.1. Global Skin Biopsy by: Disease Type (Value)
        • 5.2.1.1. Skin Cancer
        • 5.2.1.2. Actinic Keratosis
        • 5.2.1.3. Dermatitis
        • 5.2.1.4. Psoriasis
        • 5.2.1.5. Fungal Infections
        • 5.2.1.6. Eczema
        • 5.2.1.7. Others
      • 5.2.2. Global Skin Biopsy by: Techniques (Value)
        • 5.2.2.1. Shave Biopsy
        • 5.2.2.2. Punch Biopsy
        • 5.2.2.3. Wedge Biopsy
        • 5.2.2.4. Saucerization Biopsy
        • 5.2.2.5. Excisional Biopsy
        • 5.2.2.6. Incisional Biopsy
      • 5.2.3. Global Skin Biopsy by: Devices (Value)
        • 5.2.3.1. Biopsy Guns
        • 5.2.3.2. Biopsy Curettes And Punches
        • 5.2.3.3. Guidance Systems
        • 5.2.3.4. Biopsy Forceps
        • 5.2.3.5. Biopsy Needles
        • 5.2.3.6. Others
      • 5.2.4. Global Skin Biopsy by: End User (Value)
        • 5.2.4.1. Hospital and Clinics
        • 5.2.4.2. Diagnostic Laboratories
        • 5.2.4.3. Multispecialty Clinics
        • 5.2.4.4. Other
      • 5.2.5. Global Skin Biopsy Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Skin Biopsy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AccuTec, Inc. (Mexico)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cardinal Health Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Innovia Medical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Integra LifeSciences (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Vernacare (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Becton (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dickinson and Company (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. KAI Group (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Paramount Surgimed Limited (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. World Precision Instruments (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Merit Medical Systems (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Skin Biopsy Sale, by Disease Type, Techniques, Devices, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Skin Biopsy (Value)
      • 7.2.1. Global Skin Biopsy by: Disease Type (Value)
        • 7.2.1.1. Skin Cancer
        • 7.2.1.2. Actinic Keratosis
        • 7.2.1.3. Dermatitis
        • 7.2.1.4. Psoriasis
        • 7.2.1.5. Fungal Infections
        • 7.2.1.6. Eczema
        • 7.2.1.7. Others
      • 7.2.2. Global Skin Biopsy by: Techniques (Value)
        • 7.2.2.1. Shave Biopsy
        • 7.2.2.2. Punch Biopsy
        • 7.2.2.3. Wedge Biopsy
        • 7.2.2.4. Saucerization Biopsy
        • 7.2.2.5. Excisional Biopsy
        • 7.2.2.6. Incisional Biopsy
      • 7.2.3. Global Skin Biopsy by: Devices (Value)
        • 7.2.3.1. Biopsy Guns
        • 7.2.3.2. Biopsy Curettes And Punches
        • 7.2.3.3. Guidance Systems
        • 7.2.3.4. Biopsy Forceps
        • 7.2.3.5. Biopsy Needles
        • 7.2.3.6. Others
      • 7.2.4. Global Skin Biopsy by: End User (Value)
        • 7.2.4.1. Hospital and Clinics
        • 7.2.4.2. Diagnostic Laboratories
        • 7.2.4.3. Multispecialty Clinics
        • 7.2.4.4. Other
      • 7.2.5. Global Skin Biopsy Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Skin Biopsy: by Disease Type(USD Million)
  • Table 2. Skin Biopsy Skin Cancer , by Region USD Million (2017-2022)
  • Table 3. Skin Biopsy Actinic Keratosis , by Region USD Million (2017-2022)
  • Table 4. Skin Biopsy Dermatitis , by Region USD Million (2017-2022)
  • Table 5. Skin Biopsy Psoriasis , by Region USD Million (2017-2022)
  • Table 6. Skin Biopsy Fungal Infections , by Region USD Million (2017-2022)
  • Table 7. Skin Biopsy Eczema , by Region USD Million (2017-2022)
  • Table 8. Skin Biopsy Others , by Region USD Million (2017-2022)
  • Table 9. Skin Biopsy: by Techniques(USD Million)
  • Table 10. Skin Biopsy Shave Biopsy , by Region USD Million (2017-2022)
  • Table 11. Skin Biopsy Punch Biopsy , by Region USD Million (2017-2022)
  • Table 12. Skin Biopsy Wedge Biopsy , by Region USD Million (2017-2022)
  • Table 13. Skin Biopsy Saucerization Biopsy , by Region USD Million (2017-2022)
  • Table 14. Skin Biopsy Excisional Biopsy , by Region USD Million (2017-2022)
  • Table 15. Skin Biopsy Incisional Biopsy , by Region USD Million (2017-2022)
  • Table 16. Skin Biopsy: by Devices(USD Million)
  • Table 17. Skin Biopsy Biopsy Guns , by Region USD Million (2017-2022)
  • Table 18. Skin Biopsy Biopsy Curettes And Punches , by Region USD Million (2017-2022)
  • Table 19. Skin Biopsy Guidance Systems , by Region USD Million (2017-2022)
  • Table 20. Skin Biopsy Biopsy Forceps , by Region USD Million (2017-2022)
  • Table 21. Skin Biopsy Biopsy Needles , by Region USD Million (2017-2022)
  • Table 22. Skin Biopsy Others , by Region USD Million (2017-2022)
  • Table 23. Skin Biopsy: by End User(USD Million)
  • Table 24. Skin Biopsy Hospital and Clinics , by Region USD Million (2017-2022)
  • Table 25. Skin Biopsy Diagnostic Laboratories , by Region USD Million (2017-2022)
  • Table 26. Skin Biopsy Multispecialty Clinics , by Region USD Million (2017-2022)
  • Table 27. Skin Biopsy Other , by Region USD Million (2017-2022)
  • Table 28. South America Skin Biopsy, by Country USD Million (2017-2022)
  • Table 29. South America Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 30. South America Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 31. South America Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 32. South America Skin Biopsy, by End User USD Million (2017-2022)
  • Table 33. Brazil Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 34. Brazil Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 35. Brazil Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 36. Brazil Skin Biopsy, by End User USD Million (2017-2022)
  • Table 37. Argentina Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 38. Argentina Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 39. Argentina Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 40. Argentina Skin Biopsy, by End User USD Million (2017-2022)
  • Table 41. Rest of South America Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 42. Rest of South America Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 43. Rest of South America Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 44. Rest of South America Skin Biopsy, by End User USD Million (2017-2022)
  • Table 45. Asia Pacific Skin Biopsy, by Country USD Million (2017-2022)
  • Table 46. Asia Pacific Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 47. Asia Pacific Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 48. Asia Pacific Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 49. Asia Pacific Skin Biopsy, by End User USD Million (2017-2022)
  • Table 50. China Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 51. China Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 52. China Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 53. China Skin Biopsy, by End User USD Million (2017-2022)
  • Table 54. Japan Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 55. Japan Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 56. Japan Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 57. Japan Skin Biopsy, by End User USD Million (2017-2022)
  • Table 58. India Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 59. India Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 60. India Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 61. India Skin Biopsy, by End User USD Million (2017-2022)
  • Table 62. South Korea Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 63. South Korea Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 64. South Korea Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 65. South Korea Skin Biopsy, by End User USD Million (2017-2022)
  • Table 66. Taiwan Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 67. Taiwan Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 68. Taiwan Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 69. Taiwan Skin Biopsy, by End User USD Million (2017-2022)
  • Table 70. Australia Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 71. Australia Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 72. Australia Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 73. Australia Skin Biopsy, by End User USD Million (2017-2022)
  • Table 74. Rest of Asia-Pacific Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 75. Rest of Asia-Pacific Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 76. Rest of Asia-Pacific Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 77. Rest of Asia-Pacific Skin Biopsy, by End User USD Million (2017-2022)
  • Table 78. Europe Skin Biopsy, by Country USD Million (2017-2022)
  • Table 79. Europe Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 80. Europe Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 81. Europe Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 82. Europe Skin Biopsy, by End User USD Million (2017-2022)
  • Table 83. Germany Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 84. Germany Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 85. Germany Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 86. Germany Skin Biopsy, by End User USD Million (2017-2022)
  • Table 87. France Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 88. France Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 89. France Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 90. France Skin Biopsy, by End User USD Million (2017-2022)
  • Table 91. Italy Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 92. Italy Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 93. Italy Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 94. Italy Skin Biopsy, by End User USD Million (2017-2022)
  • Table 95. United Kingdom Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 96. United Kingdom Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 97. United Kingdom Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 98. United Kingdom Skin Biopsy, by End User USD Million (2017-2022)
  • Table 99. Netherlands Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 100. Netherlands Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 101. Netherlands Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 102. Netherlands Skin Biopsy, by End User USD Million (2017-2022)
  • Table 103. Rest of Europe Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 104. Rest of Europe Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 105. Rest of Europe Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 106. Rest of Europe Skin Biopsy, by End User USD Million (2017-2022)
  • Table 107. MEA Skin Biopsy, by Country USD Million (2017-2022)
  • Table 108. MEA Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 109. MEA Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 110. MEA Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 111. MEA Skin Biopsy, by End User USD Million (2017-2022)
  • Table 112. Middle East Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 113. Middle East Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 114. Middle East Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 115. Middle East Skin Biopsy, by End User USD Million (2017-2022)
  • Table 116. Africa Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 117. Africa Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 118. Africa Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 119. Africa Skin Biopsy, by End User USD Million (2017-2022)
  • Table 120. North America Skin Biopsy, by Country USD Million (2017-2022)
  • Table 121. North America Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 122. North America Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 123. North America Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 124. North America Skin Biopsy, by End User USD Million (2017-2022)
  • Table 125. United States Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 126. United States Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 127. United States Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 128. United States Skin Biopsy, by End User USD Million (2017-2022)
  • Table 129. Canada Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 130. Canada Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 131. Canada Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 132. Canada Skin Biopsy, by End User USD Million (2017-2022)
  • Table 133. Mexico Skin Biopsy, by Disease Type USD Million (2017-2022)
  • Table 134. Mexico Skin Biopsy, by Techniques USD Million (2017-2022)
  • Table 135. Mexico Skin Biopsy, by Devices USD Million (2017-2022)
  • Table 136. Mexico Skin Biopsy, by End User USD Million (2017-2022)
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Skin Biopsy: by Disease Type(USD Million)
  • Table 149. Skin Biopsy Skin Cancer , by Region USD Million (2023-2028)
  • Table 150. Skin Biopsy Actinic Keratosis , by Region USD Million (2023-2028)
  • Table 151. Skin Biopsy Dermatitis , by Region USD Million (2023-2028)
  • Table 152. Skin Biopsy Psoriasis , by Region USD Million (2023-2028)
  • Table 153. Skin Biopsy Fungal Infections , by Region USD Million (2023-2028)
  • Table 154. Skin Biopsy Eczema , by Region USD Million (2023-2028)
  • Table 155. Skin Biopsy Others , by Region USD Million (2023-2028)
  • Table 156. Skin Biopsy: by Techniques(USD Million)
  • Table 157. Skin Biopsy Shave Biopsy , by Region USD Million (2023-2028)
  • Table 158. Skin Biopsy Punch Biopsy , by Region USD Million (2023-2028)
  • Table 159. Skin Biopsy Wedge Biopsy , by Region USD Million (2023-2028)
  • Table 160. Skin Biopsy Saucerization Biopsy , by Region USD Million (2023-2028)
  • Table 161. Skin Biopsy Excisional Biopsy , by Region USD Million (2023-2028)
  • Table 162. Skin Biopsy Incisional Biopsy , by Region USD Million (2023-2028)
  • Table 163. Skin Biopsy: by Devices(USD Million)
  • Table 164. Skin Biopsy Biopsy Guns , by Region USD Million (2023-2028)
  • Table 165. Skin Biopsy Biopsy Curettes And Punches , by Region USD Million (2023-2028)
  • Table 166. Skin Biopsy Guidance Systems , by Region USD Million (2023-2028)
  • Table 167. Skin Biopsy Biopsy Forceps , by Region USD Million (2023-2028)
  • Table 168. Skin Biopsy Biopsy Needles , by Region USD Million (2023-2028)
  • Table 169. Skin Biopsy Others , by Region USD Million (2023-2028)
  • Table 170. Skin Biopsy: by End User(USD Million)
  • Table 171. Skin Biopsy Hospital and Clinics , by Region USD Million (2023-2028)
  • Table 172. Skin Biopsy Diagnostic Laboratories , by Region USD Million (2023-2028)
  • Table 173. Skin Biopsy Multispecialty Clinics , by Region USD Million (2023-2028)
  • Table 174. Skin Biopsy Other , by Region USD Million (2023-2028)
  • Table 175. South America Skin Biopsy, by Country USD Million (2023-2028)
  • Table 176. South America Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 177. South America Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 178. South America Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 179. South America Skin Biopsy, by End User USD Million (2023-2028)
  • Table 180. Brazil Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 181. Brazil Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 182. Brazil Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 183. Brazil Skin Biopsy, by End User USD Million (2023-2028)
  • Table 184. Argentina Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 185. Argentina Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 186. Argentina Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 187. Argentina Skin Biopsy, by End User USD Million (2023-2028)
  • Table 188. Rest of South America Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 189. Rest of South America Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 190. Rest of South America Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 191. Rest of South America Skin Biopsy, by End User USD Million (2023-2028)
  • Table 192. Asia Pacific Skin Biopsy, by Country USD Million (2023-2028)
  • Table 193. Asia Pacific Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 194. Asia Pacific Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 195. Asia Pacific Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 196. Asia Pacific Skin Biopsy, by End User USD Million (2023-2028)
  • Table 197. China Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 198. China Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 199. China Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 200. China Skin Biopsy, by End User USD Million (2023-2028)
  • Table 201. Japan Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 202. Japan Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 203. Japan Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 204. Japan Skin Biopsy, by End User USD Million (2023-2028)
  • Table 205. India Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 206. India Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 207. India Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 208. India Skin Biopsy, by End User USD Million (2023-2028)
  • Table 209. South Korea Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 210. South Korea Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 211. South Korea Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 212. South Korea Skin Biopsy, by End User USD Million (2023-2028)
  • Table 213. Taiwan Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 214. Taiwan Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 215. Taiwan Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 216. Taiwan Skin Biopsy, by End User USD Million (2023-2028)
  • Table 217. Australia Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 218. Australia Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 219. Australia Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 220. Australia Skin Biopsy, by End User USD Million (2023-2028)
  • Table 221. Rest of Asia-Pacific Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 222. Rest of Asia-Pacific Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 223. Rest of Asia-Pacific Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 224. Rest of Asia-Pacific Skin Biopsy, by End User USD Million (2023-2028)
  • Table 225. Europe Skin Biopsy, by Country USD Million (2023-2028)
  • Table 226. Europe Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 227. Europe Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 228. Europe Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 229. Europe Skin Biopsy, by End User USD Million (2023-2028)
  • Table 230. Germany Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 231. Germany Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 232. Germany Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 233. Germany Skin Biopsy, by End User USD Million (2023-2028)
  • Table 234. France Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 235. France Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 236. France Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 237. France Skin Biopsy, by End User USD Million (2023-2028)
  • Table 238. Italy Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 239. Italy Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 240. Italy Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 241. Italy Skin Biopsy, by End User USD Million (2023-2028)
  • Table 242. United Kingdom Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 243. United Kingdom Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 244. United Kingdom Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 245. United Kingdom Skin Biopsy, by End User USD Million (2023-2028)
  • Table 246. Netherlands Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 247. Netherlands Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 248. Netherlands Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 249. Netherlands Skin Biopsy, by End User USD Million (2023-2028)
  • Table 250. Rest of Europe Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 251. Rest of Europe Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 252. Rest of Europe Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 253. Rest of Europe Skin Biopsy, by End User USD Million (2023-2028)
  • Table 254. MEA Skin Biopsy, by Country USD Million (2023-2028)
  • Table 255. MEA Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 256. MEA Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 257. MEA Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 258. MEA Skin Biopsy, by End User USD Million (2023-2028)
  • Table 259. Middle East Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 260. Middle East Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 261. Middle East Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 262. Middle East Skin Biopsy, by End User USD Million (2023-2028)
  • Table 263. Africa Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 264. Africa Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 265. Africa Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 266. Africa Skin Biopsy, by End User USD Million (2023-2028)
  • Table 267. North America Skin Biopsy, by Country USD Million (2023-2028)
  • Table 268. North America Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 269. North America Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 270. North America Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 271. North America Skin Biopsy, by End User USD Million (2023-2028)
  • Table 272. United States Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 273. United States Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 274. United States Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 275. United States Skin Biopsy, by End User USD Million (2023-2028)
  • Table 276. Canada Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 277. Canada Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 278. Canada Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 279. Canada Skin Biopsy, by End User USD Million (2023-2028)
  • Table 280. Mexico Skin Biopsy, by Disease Type USD Million (2023-2028)
  • Table 281. Mexico Skin Biopsy, by Techniques USD Million (2023-2028)
  • Table 282. Mexico Skin Biopsy, by Devices USD Million (2023-2028)
  • Table 283. Mexico Skin Biopsy, by End User USD Million (2023-2028)
  • Table 284. Research Programs/Design for This Report
  • Table 285. Key Data Information from Secondary Sources
  • Table 286. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Skin Biopsy: by Disease Type USD Million (2017-2022)
  • Figure 5. Global Skin Biopsy: by Techniques USD Million (2017-2022)
  • Figure 6. Global Skin Biopsy: by Devices USD Million (2017-2022)
  • Figure 7. Global Skin Biopsy: by End User USD Million (2017-2022)
  • Figure 8. South America Skin Biopsy Share (%), by Country
  • Figure 9. Asia Pacific Skin Biopsy Share (%), by Country
  • Figure 10. Europe Skin Biopsy Share (%), by Country
  • Figure 11. MEA Skin Biopsy Share (%), by Country
  • Figure 12. North America Skin Biopsy Share (%), by Country
  • Figure 13. Global Skin Biopsy share by Players 2022 (%)
  • Figure 14. Global Skin Biopsy share by Players (Top 3) 2022(%)
  • Figure 15. Global Skin Biopsy share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. AccuTec, Inc. (Mexico) Revenue, Net Income and Gross profit
  • Figure 18. AccuTec, Inc. (Mexico) Revenue: by Geography 2022
  • Figure 19. Cardinal Health Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Cardinal Health Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Innovia Medical (United States) Revenue, Net Income and Gross profit
  • Figure 22. Innovia Medical (United States) Revenue: by Geography 2022
  • Figure 23. Integra LifeSciences (United States) Revenue, Net Income and Gross profit
  • Figure 24. Integra LifeSciences (United States) Revenue: by Geography 2022
  • Figure 25. Vernacare (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Vernacare (United Kingdom) Revenue: by Geography 2022
  • Figure 27. Becton (United States) Revenue, Net Income and Gross profit
  • Figure 28. Becton (United States) Revenue: by Geography 2022
  • Figure 29. Dickinson and Company (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Dickinson and Company (United Kingdom) Revenue: by Geography 2022
  • Figure 31. KAI Group (Japan) Revenue, Net Income and Gross profit
  • Figure 32. KAI Group (Japan) Revenue: by Geography 2022
  • Figure 33. Paramount Surgimed Limited (India) Revenue, Net Income and Gross profit
  • Figure 34. Paramount Surgimed Limited (India) Revenue: by Geography 2022
  • Figure 35. World Precision Instruments (United States) Revenue, Net Income and Gross profit
  • Figure 36. World Precision Instruments (United States) Revenue: by Geography 2022
  • Figure 37. Merit Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 38. Merit Medical Systems (United States) Revenue: by Geography 2022
  • Figure 39. Global Skin Biopsy: by Disease Type USD Million (2023-2028)
  • Figure 40. Global Skin Biopsy: by Techniques USD Million (2023-2028)
  • Figure 41. Global Skin Biopsy: by Devices USD Million (2023-2028)
  • Figure 42. Global Skin Biopsy: by End User USD Million (2023-2028)
  • Figure 43. South America Skin Biopsy Share (%), by Country
  • Figure 44. Asia Pacific Skin Biopsy Share (%), by Country
  • Figure 45. Europe Skin Biopsy Share (%), by Country
  • Figure 46. MEA Skin Biopsy Share (%), by Country
  • Figure 47. North America Skin Biopsy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • AccuTec, Inc. (Mexico)
  • Cardinal Health Inc. (United States)
  • Innovia Medical (United States)
  • Integra LifeSciences (United States)
  • Vernacare (United Kingdom)
  • Becton (United States)
  • Dickinson and Company (United Kingdom)
  • KAI Group (Japan)
  • Paramount Surgimed Limited (India)
  • World Precision Instruments (United States)
  • Merit Medical Systems (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 217 Pages 54 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Skin Biopsy Quantitative research analysis
Global Skin Biopsy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Skin Biopsy market are AccuTec, Inc. (Mexico), Cardinal Health Inc. (United States), Innovia Medical (United States), Integra LifeSciences (United States), Vernacare (United Kingdom), Becton (United States), Dickinson and Company (United Kingdom), KAI Group (Japan), Paramount Surgimed Limited (India), World Precision Instruments (United States) and Merit Medical Systems (United States), to name a few.
"Significant Investments by the Government to Improve Healthcare Infrastructure" is seen as one of major influencing trends for Skin Biopsy Market during projected period 2022-2028.

Know More About Global Skin Biopsy Report?

Have a Query? Click Here

Other Related Reports

Chemotherapy Induced Anemia Comprehensive Study by Drug Type (Androxy Oral, Epoetin Alfa Injection, Epogen Injection, Procrit Injection, Aranesp injection, Others), Type of Anemia (Mild Anemia, Moder...
$ 3750
Pillow Support Systems Comprehensive Study by Type (Neck Pillow, Spinal Support Pillow, Leg Raiser, Knee Support Pillow, V Pillow, Travel Pillow, Others), Application (Image Diagnosis, Surgery, Perso...
$ 3650
Beta Thalassemia Testing Comprehensive Study by Application (Hospitals, Biotechnological Laboratories, Diagnostic Laboratories, Educational Research Institutes, Pharmaceutical Industries), Technology...
$ 2500
Bradycardia Drugs Comprehensive Study by Type (Atropine, Isoproterenol, Aminophylline, Ephedrin, Scopolamine), Application (Sinus Bradycardia, Sinus Cardiac arrest, Sinus Atrial Block, Atrioventricul...
$ 3450
Hospital Acquired Pneumonia Comprehensive Study by Type (Oral Care Kit, Toothbrush, Swab, Moisturizer, Mouth Wash, Suction Tools), End-user (Hospitals, Rehabilitation Centers, Home Care Settings), Dr...
$ 3450
Opioid Tolerance Treatment Comprehensive Study by Opioid Tolerance (Innate Tolerance, Acquired Tolerance), Route of Administration (Enteral, Parenteral, Others), Drug Analysis (NMDA Antagonists, Alph...
$ 3450